KRAS and non-small cell lung carcinoma: It has been established that NSCLC patients who smoke have a higher chance of Kras mutation than those who do not smoke,36 and Kras mutation is known to be associated with MTHFD2 expression via MYC transcriptional regulation.14, 37, 38